A teenage boy who received Sarepta’s Duchenne muscular dystrophy gene therapy Elevidys died from liver failure, the biotech ...

The British stem cell company bit.bio has reduced its workforce by 25%, impacting most of the therapeutics division, founder ...

Following a court order, HHS won't fire more than 2,800 probationary employees it sought to cut — but it won't let them come ...

In a surprise move, the longtime CEO of Stoke Therapeutics is leaving the company, weeks before the Phase 3 trial of its lead ...

Sofinnova Partners launches €165M Biovelocita II fund for early-stage science in Italy, France, UK & Denmark, backed by Amgen ...

Kurt Knight, former Amwell exec, named CEO of nutrition telehealth company Foodsmart. Company raised $200M from TPG, serves 2.2M+ members via Medicaid, Medicare & commercial plans.

Cell therapy biotech RegCell is hoping to bridge science from Japan with the US biotech industry to develop new cell therapies for autoimmune conditions.

Arbor Biotechnologies, a startup founded by CRISPR pioneer Feng Zhang nine years ago, has closed a $73.9 million Series C financing to bring its first therapy into clinical trials ...

A year after the Biosecure Act was introduced, WuXi AppTec’s US revenue growth continued to drop significantly, and the ...

Maxion Therapeutics has secured $72 million in an oversubscribed Series A raise, with Eli Lilly pitching in, to advance its ...

Boston biotech hC Bioscience shuts down after failed hemophilia A program, CEO Leslie Williams says. Company had raised $40M ...

AstraZeneca to acquire EsoBiotec for $425M upfront, with $575M in potential milestones. Deal centers on platform technology ...